2011年,对于中国的动保行业来讲是值得记住的一年。《兽药经营管理规范(GSP)》的推行在一定程度上打击了经营不规范的中小企业,这对国内大型的动保企业是个利好消息,大家似乎看到期盼已久的“中国动保行业的春天”终于来了。但是与此同时,我们看到国外的动保企业也开始了在中国大规模的布局,2011年11月3日,全球最大的生物制药企业美国辉瑞公司下属的辉瑞动保与吉林国原动物保健品有限公司共同出资成 In 2011, it is a memorable year for China’s animal health and insurance industry. The implementation of the “Provisional Regulations on the Management of Veterinary Drugs (GSP)” has hit a certain extent the non-standard operation of small and medium-sized enterprises, which is good news for the domestic large-scale dynamic security companies. Everyone seems to have seen the long-awaited “China Mobile Industry spring ”finally came. However, at the same time, we have seen that foreign-funded enterprises also started a large-scale layout in China. On November 3, 2011, Pfizer, a subsidiary of Pfizer, the largest biopharmaceutical company in the world, Co., Ltd. jointly funded into